The settlement will provide Celera with at least $7 million from the defendants in the litigation, and sets certain prohibitions, such as the soliciting or hiring of Berkeley HeartLab employees.
Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US.
The company has completed paying off a $600,000 settlement agreement for using Health Discovery Corporation's SVM IP for protein biomarker discovery.
The settlement will end a dispute dating back more than two years and likely help CombiMatrix as it continues to seek "strategic options" for the company.
The agreement to issue additional shares settles claims brought against Sequenom for alleged breach of representations and warranties made by Sequenom in its asset purchase agreement.
The settlement ends a one-year-old dispute regarding mass-spec based patents held by Sequenom.
The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.
Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.
Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.
In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.